Skip to main content

Table 6 Comparison between WT1 genotyping and hMICL expression to basal laboratory data of AML patients

From: The prognostic impact of Wilms tumor-1 polymorphism (rs16754) and human myeloid inhibitory C-type lectin-like receptor expression in cytogenetically normal-acute myeloid leukemia

Parameters (M ± SD)

WT1 (N = 63)

P value

HMICL (N = 63)

P value

GG + AG (N = 17)

AA (N = 46)

Negative (N = 8)

Positive (N = 55)

Age

49.1 ± 16.5

47.5 ± 14.1

0.719

54.4 ± 17.8

47.0 ± 14.0

0.292

TLC

47.1 ± 45.9

56.2 ± 54.3

0.951

64.0 ± 61.0

54.0 ± 50.0

0.408

HB

8.1 ± 1.8

7.7 ± 1.6

0.477

7.6 ± 1.6

7.8 ± 1.7

0.758

Platelets

92.5 ± 60.9

81.2 ± 72.5

0.654

87.3 ± 73.1

75.2 ± 66.7

0.680

Blast count

63.6 ± 22.7

57.9 ± 24.3

0.392

75.7 ± 17.2

57.1 ± 23.8

0.020

LDH

882 ± 714

600 ± 564

0.154

927 ± 873

647 ± 563

0.522

ALT

29.6 ± 15.8

31.8 ± 18.4

0.649

35.8 ± 16.3

30.5 ± 17.8

0.415

AST

23.3 ± 7.9

27.4 ± 13.1

0.148

23.5 ± 10.2

26.7 ± 12.3

0.439

Creatinine

1.4 ± 0 .9

1.7 ± 1.5

0.414

1.1 ± 0.8

1.7 ± 1.4

0.142

BUN

26.8 ± 13.7

33.3 ± 22.6

0.168

24.3 ± 13.0

32.6 ± 21.4

0.154

Survival (months)

18.9 ± 4.6

7.1 ± 5.7

0.000

21.8 ± 2.0

8.6 ± 6.5

0.001